Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine
Open Access
- 21 June 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 10, 1211
- https://doi.org/10.3389/fimmu.2019.01211
Abstract
The present study aims to determine whether 17DD-YF-specific humoral and cellular immunological memory is maintained 8-years after primary vaccination with subdoses (10,447IU;3,013IU;587IU;158IU;31IU). For this purpose, this follow-up study was carried out in a subset of volunteers (n = 98) originally enrolled in the dose-response study in 2009 and 46 non-vaccinated controls. Our results demonstrated that vaccinees, who had seroconverted following primary vaccination and had not been revaccinated, present similar neutralizing antibodies levels and YF-specific cellular memory, particularly CMCD4 and EMCD8 as compared to the reference full dose (27,476IU). Although, PRNT seropositivity rates were similar across subgroups (94, 82, 83, 94, 80, and 91%, correspondingly), only doses above 587IU elicited similar iterative proportion of seropositivity rates, calculated as a progressive decrease on seropositivity rates along time (89, 80, 80, and 91%, respectively) as compared to 158IU and 31IU (68 and 46%, respectively). Noteworthy were the strong positive correlations (“EMCD4,EMCD8” and “TNFCD8,IFNCD8”) observed in most subdoses, except for 31IU. Major similarities underscored the preserved antibody titers and the outstanding levels of EMCD8, relevant correlates of protection for YF-specific immunity. These findings provide evidences to support the regular use of dose sparing strategy for YF vaccine in adults.Keywords
This publication has 23 references indexed in Scilit:
- Booster dose after 10 years is recommended following 17DD-YF primary vaccinationHuman Vaccines & Immunotherapeutics, 2015
- Yellow feverJournal of Clinical Virology, 2015
- Duration of post-vaccination immunity against yellow fever in adultsVaccine, 2014
- Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timelineBMC Infectious Diseases, 2014
- Yellow Fever Outbreaks in Unvaccinated Populations, Brazil, 2008–2009PLoS Neglected Tropical Diseases, 2014
- Efficacy and Duration of Immunity after Yellow Fever Vaccination: Systematic Review on the Need for a Booster Every 10 YearsThe American Journal of Tropical Medicine and Hygiene, 2013
- 17DD yellow fever vaccineHuman Vaccines & Immunotherapeutics, 2013
- Yellow fever outbreak affecting Alouatta populations in southern Brazil (Rio Grande do Sul State), 2008–2009American Journal of Primatology, 2011
- The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell ResponseThe Journal of Immunology, 2009
- Intradermally Administered Yellow Fever Vaccine at Reduced Dose Induces a Protective Immune Response: A Randomized Controlled Non-Inferiority TrialPLOS ONE, 2008